This one-hour, on-demand, journal article-based activity examines the prevalence of continued substance use in the United States among adults who self-identified as being in recovery, including demographic and psychosocial factors. Since many adults in recovery continue to use substances, such as alcohol and cannabis, treatment and recovery services may enhance participation and effectiveness by accommodating goals that do not require complete abstinence.

This one-hour, on-demand, journal article-based activity reviews findings from a systematic review and meta-analysis on the effectiveness and safety of naltrexone as a standalone pharmacotherapy for amphetamine-type stimulant use disorder (ATSUD). Drawing from five randomized controlled trials, the article examines naltrexone’s impact on stimulant use, study retention, craving, and adverse effects.

This one-hour, on-demand, journal article-based activity explores the rising US drug overdose death rate from 2002 to 2022, with a focus on the emerging role of kratom (mitragynine). Recent data on kratom detection in overdose cases provides consideration for how these findings can inform overdose prevention efforts and guide the development of targeted interventions.

This one-hour, on-demand, journal article-based activity explores liver injuries linked to medications used in the treatment of alcohol use disorder (AUD), based on findings from the Drug-Induced Liver Injury Network (DILIN) study. The activity reviews clinical patterns, implicated drugs, and outcomes, offering insights that can inform safer prescribing practices and monitoring strategies in the care of individuals with AUD.

This 1-hour, webinar recording is part of 4 four-session webinar series that will translate clinical guidelines into actionable strategies for safer benzodiazepine tapering. This webinar includes expert-led discussions and case-based applications that will cover Addressing Benzodiazepine Tapering Challenges.